SARS CoV2 permissive colon cancer cell line DLD1 validated for Spike protein binding and SARS CoV 2 pseudovirion assay
| Inventor | Institute |
|---|---|
| T.R. Santhosh Kumar | Rajiv Gandhi Centre for Biotechnology |
| SKU: | 161166 |
|---|---|
| Product description: | SARS CoV2 permissive colon cancer cell line DLD1 validated for Spike protein binding and SARS CoV 2 pseudovirion assay |
| Gender: | Male |
| CRISPR: | No |
| Conditional: | No |
| Parental cell line: | DLD-1 |
| Disease: | Cancer |
| Cat. #: | 161166 |
|---|---|
| Cancer types: | Colorectal cancer |
| Research Fields: | Cancer; Disease (not cancer); Metabolism |
| Organism: | Human |
| Tissue: | Colon |
| Gender: | Male |
| Model: | Transgenic |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Colorectal adenocarcinoma |
| Initial handling information: | Resuscitation: Rapidly thaw the frozen ampoule in a water bath at 37?°C for 1-2 minutes. Transfer the contents to a centrifuge tube and slowly add 5-10ml of pre-warmed growth media. Remove a sample for counting. Centrifuge at 100-150g for 2-3 minutes to pellet cells (a centrifugation step to remove the cryoprotectant is essential. Seed at the recommend density, e.g. greater than 10,000 cells per cm2. |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry Ice |
| Growth medium: | DMEM with 2mM L-Glutamine and 10% FBS (Heat inactivated), or RPMI 1640 with 2mM L-Glutamine and 10 Fetal Bovine serum. |
| Subculture routine: | Subculture non-confluent cultures using trypsin/EDTA and 1:3 to 1:4, i.e. seeding at 1-4 x10,000 cells/cm? . |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Storage medium: | Growth medium + 10% DMSO |
| References: |
Unpublished |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.